Product Details:
| Manufacturer | NOVARTIS |
| Packaging Size | 10’s |
| Brand | Jakavi |
| Composition | Ruxolitinib |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Therapeutic Uses | Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients |
| Treatment | Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients |
Jakavi is indicated for the??treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.
Reviews
There are no reviews yet.